About Investment Accelerator Fund - Life Sciences The Investment Accelerator Fund - Life Sciences (IAF - LS) helps accelerate the growth
of life sciences companies in Ontario.
Wilson Sonsini advises an impressive
array of life sciences companies on both public and private equity and debt financings, M&A, securities and corporate governance matters.
Facilitated by Dr. Jason Field, Executive Director of Life Sciences Ontario (LSO), the panel discussion will focus on «The Road to Commercialization — The
story of life sciences companies, their challenges, opportunities and successes».
In 2001 Bissinger, the
CEO of a life sciences company, teamed up with astronomers Tim Castellano of NASA's Ames Research Center and Greg Laughlin of the University of California at Santa Cruz.
Dr. Taylor has founded a
number of life science companies including Cellomics, Inc., which was sold in 2003 to Fisher Scientific; Cellumen, Inc.; and, most recently, Cernostics, a tissue systems biology, diagnostics company.
Alan Gold: While the share
prices of life science companies are certainly dynamic, we believe the foundation of our business and the overall life science industry could not be more solid.
Our lawyers — who include the former general counsel of one of the largest health insurers in the country and senior in - house lawyers from an
array of life sciences companies — know the industry from the inside.